-
Cannabidiol Drug Maker Acquired in $7.2B Deal
A developer of treatments for rare neurological diseases derived from cannabis is being acquired by Jazz Pharmaceuticals in a $7.2 billion deal.
-
Moving Your Business Forward After Covid
It is the ideal time to start making some goals and having some ideas on what you might want to do next.
-
One-Dose Covid-19 Vaccine Shown to Prevent Hospitalization
Results from four international clinical trials show high disease prevention rates from one dose of the Oxford-AstraZeneca Covid-19 vaccine.
-
Trial Testing Ultrasound Treatment for Liver Cancer
A clinical trial is underway assessing the safety of an experimental non-invasive ultrasound therapy to treat liver cancer.
-
Covid-19 Vaccine Shown Safe, Effective in Russian Test
Interim results from a clinical trial in Russia of a two-dose vaccine show a high efficacy rate in preventing Covid-19 disease and few serious adverse effects.
-
U.S. Supports Home Smartphone Covid-19 Test
The U.S. government is funding large-scale production of Covid-19 home test kits that send results to the user’s smartphone.
-
Cancer Immunotherapy Adapted for HIV
A biotechnology company is adapting and licensing its immunotherapy process, originally designed for cancer, as a cure for HIV infections.
-
Infographic – More Eager for Covid-19 Vaccine
Surveys by the polling company Ipsos indicate publics in 15 countries overall are more willing than before to get vaccinated against Covid-19 disease.
-
Novavax, J&J Return Mixed Covid-19 Vaccine Results
Results from international clinical trials show largely favorable results for two Covid-19 vaccines, but still limitations against the South African variant.
-
Improving Customer Service in Medical Centres Should be a Priority in 2021
Improving customer management and care should be a top priority for medical facilities now, as that is where the situation is likely to be the most challenging.